Physiological and Structural Differences Between Enterococcus faecalis JH2-2 and Mutant Strains Resistant to (P)-Divercin RV41

Probiotics and Antimicrobial Proteins
Ségolène CalvezDjamel Drider

Abstract

The aim of this study was to show the differences that could exist at the physiological and structural levels between Enterococcus faecalis JH2-2 (wild type) and three mutant strains resistant to divercin RV41. These mutant strains were recently isolated and characterized for their intermediate resistance to recombinant DvnRV41; a subclass IIa bacteriocin produced by Escherichia coli. These mutant strains were named 35A1 (altered in gene coding phosphoesterase activity), 35H1 (altered in gene coding σ(54) factor) and 36H4 (altered in gene coding glycerophosphodiesterase). The growth and resistance of each strain were tested against lysozyme. The inhibitory substance did not show any cross-resistance but exhibited an additive effect ascribed to the combined action of lysozyme and (P)-DvnRV41. The use of Fourier transform infrared spectroscopy (FT-IR) allowed to unravelling differences at the structural levels between the aforementioned strains. Thus, mutants 35H1 and 36H4 showed clear differences from mutant 35A1 and wild-type strain. These differences were located, mainly in the fatty acid region and in the polysaccharide composition. This study contributes to understanding more the resistance/sensitivity of Ent. faecalis to (P...Continue Reading

References

Jan 1, 1991·Journal of General Microbiology·D HelmD Naumann
Aug 1, 1980·Journal of Bacteriology·Y Yagi, D B Clewell
Sep 1, 1993·FEMS Microbiology Reviews·T R Klaenhammer
Jun 11, 1998·Emerging Infectious Diseases·M M HuyckeM S Gilmore
Sep 24, 1999·International Journal of Antimicrobial Agents·M B WachsmanC E Coto
Jan 21, 2000·FEMS Microbiology Reviews·S EnnaharA Ishizaki
Aug 10, 2000·Biopolymers·I F Nes, H Holo
Aug 30, 2001·Applied and Environmental Microbiology·C M FranzW H Holzapfel
Jan 5, 2002·International Journal of Food Microbiology·J ClevelandM L Chikindas
Apr 12, 2002·Current Pharmaceutical Design·Hisham R IbrahimAntonio Pellegrini
Apr 30, 2003·The Journal of Antimicrobial Chemotherapy·Aaron InghamMark Tizard
Apr 30, 2003·Antiviral Research·Mónica B WachsmanCelia E Coto
Jan 20, 2004·The Journal of Antimicrobial Chemotherapy·Carlos J MinahkRoberto D Morero
May 5, 2005·International Journal of Antimicrobial Agents·Svetoslav D TodorovLeon M T Dicks
Oct 6, 2005·Nature Reviews. Microbiology·Paul D CotterR Paul Ross
Jan 5, 2006·Applied and Environmental Microbiology·Astrid OustAchim Kohler
Jun 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·Djamel DriderHervé Prévost
Sep 8, 2006·Journal of Clinical Microbiology·Nathan ShankarLars B Jensen
Oct 21, 2009·Antimicrobial Agents and Chemotherapy·Jitka RihakovaDjamel Drider

❮ Previous
Next ❯

Citations

Nov 19, 2011·Journal of Applied Microbiology·T JacquetA-M Revol-Junelles
Mar 1, 2012·Probiotics and Antimicrobial Proteins·Gurpreet KaurArun Bhardwaj
Jun 22, 2017·EcoSal Plus·James T Riordan, Avishek Mitra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.